Use of non invasive prenatal fetal blood group genotyping in the monitoring of allo-immunized pregnant women: Experience of the french national center for perinatal hemobiology (CNRHP)
N. Da-Silva(Sorbonne Université), Agnès Mailloux(Sorbonne Université), Hélène Delaby(Assistance Publique – Hôpitaux de Paris), Olivier Oudin(Sorbonne Université), S. Disdier(Sorbonne Université), Cécile Toly‐Ndour(Sorbonne Université), Stéphanie Huguet‐Jacquot(Assistance Publique – Hôpitaux de Paris), M. Mordier(Sorbonne Université), A. Cortey(Sorbonne Université), Priscilla Saulet(Sorbonne Université)
Cited by 0
Related Papers
Proteomic study of human umbilical vein endothelial cells in culture
|PROTEOMICS|2003|100
Anticancer drugs induce necrosis of human endothelial cells involving both oncosis and apoptosis
|European Journal of Cell Biology|2001|82
Proteomics of human umbilical vein endothelial cells applied to etoposide‐induced apoptosis
|PROTEOMICS|2005|70
Management of Very Early Fetal Anemia Resulting From Red-Cell Alloimmunization Before 20 Weeks of Gestation
|Obstetrics and Gynecology|2011|49
Determination of optimal timing of serial <i>in‐utero</i> transfusions in red‐cell alloimmunization
|Ultrasound in Obstetrics and Gynecology|2014|41